Matrix metalloproteinases are a family of zinc and calcium dependent endopeptidases with the combined ability to degrade all the components of the extracellular matrix. MMP-10 (stromelysin 2) degrades a broad range of substrates including gelatin, collagen types III, IV and V, fibronectin, aggrecan, and pig cartilage proteoglycan. MMP-10 can activate other MMPs such as MMP-1 and MMP-8. MMP-10 is expressed in keratinocytes, T cells, menstrual endometrium, and a few tumor samples. Structurally, MMP-10 may be divided into four distinct domains: a pro-domain which is cleaved upon activation, a catalytic domain containing the zinc binding site; a short linker region, and a carboxyl terminal hemopexin-like domain.
Scientific images may be resized, cropped, or adjusted for brightness or contrast for presentation purposes. These updates are limited to presentation and do not affect the underlying scientific interpretation of the data. Where available, additional source data may be provided upon request.
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Tyr18-Cys476
Accession # P09238
Specificity
Clonality
Host
Isotype
Endotoxin Level
Scientific Data Images for Human MMP-10 Antibody (117239)
Detection of Human MMP-10 by Immunohistochemistry
Co-localisation of MMPs with markers of classical activation in human atherosclerotic plaques.(A) Serial sections were stained by peroxidase with anti-CD68 (A. CD68) and by dual immuno-fluorescence with anti-MMP-1 or anti-MMP-10 (red) together with anti-COX-2 or p65RelA (green) as shown, and the images were superimposed digitally. Nuclear localised p65RelA (NF-kB*) was detected because of the shift in nuclear counterstain colour from dark blue (DAPI alone) to sky blue (blue plus green) in the superimposed image. (B) Areas rich in macrophages identified from the peroxidase stain were identified in the serial section. Cells in the whole field were counted and a percentage of each staining pattern calculated. Values are means ± SEM, n = 6, * p<0.05. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/22880008), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of MMP-10 by Immunohistochemistry
Increased expression levels of MMP-1 and MMP-10 in hypoxia-induced PAH rat lungs. Rats were exposed to normoxia or hypoxia (10% O2) for 8 weeks (n=10 per group). (A) RVSP, (B) right ventricular hypertrophy were analyzed. (C) Lung sections were stained for EvG. Scale bars, 50 μm. (D) The ratio of media thickness to lumen diameter were determined using Image J analysis software. Group comparisons were analyzed by one-way analysis of variance (ANOVA) with Dunnett's post-hoc test. Data are represented as the mean ±SD. #P < 0.01, hypoxia vs normoxia group. (E) Immunohistochemistry of MMP-1 and MMP-10 in lung tissue sections of hypoxic rats and the control. Scale bars, 100 μm. Representative the quantifications (right) of MMP-1 and MMP-10 protein in lung tissue sections of hypoxic rats and the control. (F) Whole lung tissues were isolated from hypoxia-induced PAH rats and western blotting was used to measure the level of MMP-1 and MMP-10. (G, H) The lung sections of rats from each group were co-immunostained with CD68 and MMP-1 or MMP-10 antibodies and DAPI. Scale bars, 20 µm. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34975336), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of MMP-10 by Western Blot
MAPKs, PI3K, and STATs pathways are involved in the regulation of MMP-1 and MMP-10 expression in M1-polarized macrophages from PAH patients. (A-D) M0 macrophages cultured in medium without M-CSF for 16 h. Subsequently, cells were pretreated in the absence of inhibitor or with PD98059 (10 μM), SB203580 (10 μM), SP600125 (10 μM), LY-294002 (10 μM), Fludarabine (Flu, 1 μM,STAT1 inhibitor), or S3I-201 (50 μM, STAT3 inhibitor) for 1h and then incubated in the presence or absence of LPS/INF-gamma for 18 h. After stimulation, cells were further exposed either to hypoxia or normoxia for 24 h. The expression level of MMP-10 by western blotting was determined. Data are expressed as the mean ± SD of three independent experiments. *P < 0.05; #P < 0.01, as compared with LPS/INF-gamma group under hypoxic conditions. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34975336), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of MMP-10 by Western Blot
MMP-10 exacerbates proliferation and migration of rat PAH PASMC. (A) PASMC isolated from MCT- and hypoxia-induced rats. Cells were infected with 0, 1, 10, or 20 MOI of Adv-MMP-10 for 48 h. (B) Cells were infected with 10 MOI of Adv-MMP-10 for 48 or 72 h. The expression level of MMP-10 by western blotting in cell lysates and culture medium were determined. (C)MCT- and hypoxia-PASMC were infected with 0, 10 or 20 MOI of Adv-MMP-10 for 72 h. Cell viability were measured by alamar blue assay. (D) MCT- and hypoxia-PASMC were infected with 0, 1, 10 or 20 MOI of Adv-MMP-10 for 72 h. The expression level of cyclin D1 and PCNA by western blotting in cell lysates were determined. (E) Cell proliferation were measured using BrdU assay. (F) Scratch-wound closure monitored over time in Adv-MMP-10 infected MCT- and hypoxia-PASMC. Representative bright-field images and quantification of the wound closure expressed as the remaining area uncovered by the cells. Data are expressed as the mean ± SD of three independent experiments. *P < 0.05; #P < 0.01, as compared with the basal level. In C, E, F, G, **P < 0.05; ##P < 0.01, MCT-PASMC/20 MOI Adv-MMP-10 or hypoxia-PASMC/20 MOI Adv-MMP-10 vs PBS-PAMC/20 MOI Adv-MMP-10. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34975336), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of MMP-10 by Immunohistochemistry
Increased expression levels of MMP-1 and MMP-10 in MCT-induced PAH rat lungs. Rats were treated with MCT (60 mg/kg) or PSB for 28 days (n=10 per group). (A) Assessment of right ventricular systolic pressure (RVSP), (B) right ventricular hypertrophy (Fulton index, the ratio of right ventricular weight to left ventricular plus septal weight. (C) Lung sections were stained for Elastic van Gieson (EvG). Scale bars, 50 μm. (D) The ratio of media thickness to lumen diameter were determined using Image J analysis software. Group comparisons were analyzed by one-way analysis of variance (ANOVA) with Dunnett's post-hoc test. Data are represented as the mean ±SD. #P < 0.01, MCT vs PBS group. (E) Immunohistochemistry of MMP-1 and MMP-10 in lung tissue sections of MCT-rats and the control. Scale bars, 100 μm. Representative the quantifications (right) of MMP-1 and MMP-10 protein in lung tissue sections of MCT-rats and the control. (F) Whole lung tissues were isolated from MCT-induced PAH rats and western blotting was used to measure the level of MMP-1 and MMP-10. (G, H) Immunofluorescence for the macrophage markers CD68 (red) and MMP-1 (green) or MMP-10 (green) and nuclei with DAPI dye (blue) in lung sections. Scale bars, 20 µm. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34975336), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of MMP-10 by Immunocytochemistry/ Immunofluorescence
MMP-10 promotes proliferation and migration in human PASMC. (A) Human PASMC were infected with 0, 1, 10, or 20 MOI of Adv-MMP-10, an adenovirus containing human MMP-10 gene, for 48 h. (B) Cells were infected with 10 MOI of Adv-MMP-10 for 48 or 72 h. The expression level of MMP-10 by western blotting in cell lysates and culture medium were determined. (C) Human PASMC were infected with 0, 10 or 20 MOI of Adv-MMP-10 for 24, 48 or 72 h. Cell viability were measured by alamar blue assay. (D) Human PASMC were infected with 0, 1, 10 or 20 MOI of Adv-MMP-10 for 48 h. The expression level of cyclin D1 and PCNA by western blotting in cell lysates were determined. (E) Cell proliferation were measured using BrdU assay. (F) Scratch-wound closure monitored over time in Adv-MMP-10 infected human PASMC. Representative bright-field images and quantification of the wound closure expressed as the remaining area uncovered by the cells. Data are expressed as the mean ± SEM of three independent experiments. *P < 0.05; #P < 0.01, as compared with the basal level. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34975336), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of MMP-10 by Western Blot
MMP-10 exacerbates proliferation and migration of rat PAH PASMC. (A) PASMC isolated from MCT- and hypoxia-induced rats. Cells were infected with 0, 1, 10, or 20 MOI of Adv-MMP-10 for 48 h. (B) Cells were infected with 10 MOI of Adv-MMP-10 for 48 or 72 h. The expression level of MMP-10 by western blotting in cell lysates and culture medium were determined. (C)MCT- and hypoxia-PASMC were infected with 0, 10 or 20 MOI of Adv-MMP-10 for 72 h. Cell viability were measured by alamar blue assay. (D) MCT- and hypoxia-PASMC were infected with 0, 1, 10 or 20 MOI of Adv-MMP-10 for 72 h. The expression level of cyclin D1 and PCNA by western blotting in cell lysates were determined. (E) Cell proliferation were measured using BrdU assay. (F) Scratch-wound closure monitored over time in Adv-MMP-10 infected MCT- and hypoxia-PASMC. Representative bright-field images and quantification of the wound closure expressed as the remaining area uncovered by the cells. Data are expressed as the mean ± SD of three independent experiments. *P < 0.05; #P < 0.01, as compared with the basal level. In C, E, F, G, **P < 0.05; ##P < 0.01, MCT-PASMC/20 MOI Adv-MMP-10 or hypoxia-PASMC/20 MOI Adv-MMP-10 vs PBS-PAMC/20 MOI Adv-MMP-10. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34975336), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of MMP-10 by Western Blot
MMP-10 promotes proliferation and migration in human PASMC. (A) Human PASMC were infected with 0, 1, 10, or 20 MOI of Adv-MMP-10, an adenovirus containing human MMP-10 gene, for 48 h. (B) Cells were infected with 10 MOI of Adv-MMP-10 for 48 or 72 h. The expression level of MMP-10 by western blotting in cell lysates and culture medium were determined. (C) Human PASMC were infected with 0, 10 or 20 MOI of Adv-MMP-10 for 24, 48 or 72 h. Cell viability were measured by alamar blue assay. (D) Human PASMC were infected with 0, 1, 10 or 20 MOI of Adv-MMP-10 for 48 h. The expression level of cyclin D1 and PCNA by western blotting in cell lysates were determined. (E) Cell proliferation were measured using BrdU assay. (F) Scratch-wound closure monitored over time in Adv-MMP-10 infected human PASMC. Representative bright-field images and quantification of the wound closure expressed as the remaining area uncovered by the cells. Data are expressed as the mean ± SEM of three independent experiments. *P < 0.05; #P < 0.01, as compared with the basal level. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34975336), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of MMP-10 by Western Blot
MMP-10 promotes proliferation and migration in human PASMC. (A) Human PASMC were infected with 0, 1, 10, or 20 MOI of Adv-MMP-10, an adenovirus containing human MMP-10 gene, for 48 h. (B) Cells were infected with 10 MOI of Adv-MMP-10 for 48 or 72 h. The expression level of MMP-10 by western blotting in cell lysates and culture medium were determined. (C) Human PASMC were infected with 0, 10 or 20 MOI of Adv-MMP-10 for 24, 48 or 72 h. Cell viability were measured by alamar blue assay. (D) Human PASMC were infected with 0, 1, 10 or 20 MOI of Adv-MMP-10 for 48 h. The expression level of cyclin D1 and PCNA by western blotting in cell lysates were determined. (E) Cell proliferation were measured using BrdU assay. (F) Scratch-wound closure monitored over time in Adv-MMP-10 infected human PASMC. Representative bright-field images and quantification of the wound closure expressed as the remaining area uncovered by the cells. Data are expressed as the mean ± SEM of three independent experiments. *P < 0.05; #P < 0.01, as compared with the basal level. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/34975336), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Human MMP-10 Antibody (117239)
Immunohistochemistry
Sample: Immersion fixed paraffin-embedded sections of human intestine
Immunoprecipitation
Sample: Conditioned cell culture medium spiked with Recombinant Human MMP‑10 (Catalog # 910‑MP), see our available Western blot detection antibodies
Western Blot
Sample: Recombinant Human MMP‑10 Western Blot Standard (Catalog # WBC026)
Neutralization
Reviewed Applications
Read 1 review rated 1 using MAB9101 in the following applications:
Formulation, Preparation, and Storage
Purification
Reconstitution
Reconstitute at 0.5 mg/mL in sterile PBS. For liquid material, refer to CoA for concentration.
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Calculators
Background: MMP-10
Long Name
Alternate Names
Entrez Gene IDs
Gene Symbol
UniProt
Additional MMP-10 Products
Product Documents for Human MMP-10 Antibody (117239)
Certificate of Analysis
To download a Certificate of Analysis, please enter a lot or batch number in the search box below.
Note: Certificate of Analysis not available for kit components.
Product Specific Notices for Human MMP-10 Antibody (117239)
For research use only
Related Research Areas
Citations for Human MMP-10 Antibody (117239)
Customer Reviews for Human MMP-10 Antibody (117239) (1)
Have you used Human MMP-10 Antibody (117239)?
Submit a review and receive an Amazon gift card!
$25/€18/£15/$25CAN/¥2500 for a review with an image
$10/€7/£6/$10CAN/¥1110 for a review without an image
Submit a review
Customer Images
-
Application: Immunocytochemistry/ImmunofluorescenceSample Tested: Adult lungSpecies: HumanVerified Customer | Posted 03/13/2019Doesn't work with and without citrate retrieval, Used IgG as negative control and a different MMP10 antibody as a positive control.Bio-Techne ResponseThank you for reviewing our product. We are sorry to hear that this antibody did not perform as expected. We have been in touch with the customer to resolve this issue according to our Product Guarantee and to the customer’s satisfaction.
There are no reviews that match your criteria.
Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
- Antigen Retrieval Protocol (PIER)
- Antigen Retrieval for Frozen Sections Protocol
- Appropriate Fixation of IHC/ICC Samples
- Cellular Response to Hypoxia Protocols
- Chromogenic IHC Staining of Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Protocol
- Chromogenic Immunohistochemistry Staining of Frozen Tissue
- ClariTSA™ Fluorophore Kits
- Detection & Visualization of Antibody Binding
- Fluorescent IHC Staining of Frozen Tissue Protocol
- Graphic Protocol for Heat-induced Epitope Retrieval
- Graphic Protocol for the Preparation and Fluorescent IHC Staining of Frozen Tissue Sections
- Graphic Protocol for the Preparation and Fluorescent IHC Staining of Paraffin-embedded Tissue Sections
- Graphic Protocol for the Preparation of Gelatin-coated Slides for Histological Tissue Sections
- IHC Sample Preparation (Frozen sections vs Paraffin)
- Immunofluorescent IHC Staining of Formalin-Fixed Paraffin-Embedded (FFPE) Tissue Protocol
- Immunohistochemistry (IHC) and Immunocytochemistry (ICC) Protocols
- Immunohistochemistry Frozen Troubleshooting
- Immunohistochemistry Paraffin Troubleshooting
- Immunoprecipitation Protocol
- Preparing Samples for IHC/ICC Experiments
- Preventing Non-Specific Staining (Non-Specific Binding)
- Primary Antibody Selection & Optimization
- Protocol for Heat-Induced Epitope Retrieval (HIER)
- Protocol for Making a 4% Formaldehyde Solution in PBS
- Protocol for VisUCyte™ HRP Polymer Detection Reagent
- Protocol for the Preparation & Fixation of Cells on Coverslips
- Protocol for the Preparation and Chromogenic IHC Staining of Frozen Tissue Sections
- Protocol for the Preparation and Chromogenic IHC Staining of Frozen Tissue Sections - Graphic
- Protocol for the Preparation and Chromogenic IHC Staining of Paraffin-embedded Tissue Sections
- Protocol for the Preparation and Chromogenic IHC Staining of Paraffin-embedded Tissue Sections - Graphic
- Protocol for the Preparation and Fluorescent IHC Staining of Frozen Tissue Sections
- Protocol for the Preparation and Fluorescent IHC Staining of Paraffin-embedded Tissue Sections
- Protocol for the Preparation of Gelatin-coated Slides for Histological Tissue Sections
- R&D Systems Quality Control Western Blot Protocol
- TUNEL and Active Caspase-3 Detection by IHC/ICC Protocol
- The Importance of IHC/ICC Controls
- Troubleshooting Guide: Immunohistochemistry
- Troubleshooting Guide: Western Blot Figures
- Western Blot Conditions
- Western Blot Protocol
- Western Blot Protocol for Cell Lysates
- Western Blot Troubleshooting
- Western Blot Troubleshooting Guide
- View all Protocols, Troubleshooting, Illustrated assays and Webinars